Company profile: Integrated Proteomics
1.1 - Company Overview
Company description
- Provider of a comprehensive proteomic data analysis solution, the Integrated Proteomics Pipeline (IP2), designed to make proteomics data analysis easy and streamlined for universities, research hospitals, pharmaceutical companies, and biological research institutes.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Integrated Proteomics
Jumpcode Genomics
HQ: United States
Website
- Description: Provider of CRISPR-mediated rRNA and DNA depletion kits for sequencing workflows, improving sensitivity and performance. Solutions include single-cell RNA boost kits (CRISPRclean, DepleteX) to remove uninformative transcripts and undesired fragments; bulk RNA/DNA depletion for stranded RNA-Seq; mitochondrial DNA, nasopharyngeal RNA, and human DNA depletion to enhance genomic and microbial analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jumpcode Genomics company profile →
Inova
HQ: France
Website
- Description: Provider of digital partnering solutions for the biopharma and life sciences industry, offering Inpart, a platform connecting academic researchers, universities and industry to facilitate collaboration and commercialization; Connect, an algorithm- and machine learning–based matchmaking platform aligning biotech assets with biopharma needs; Deal, a CRM for biopharma partnering; and Event, software for managing in-person or online life science conferences and meetings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inova company profile →
PatientIQ
HQ: United States
Website
- Description: Provider of a cloud-based patient outcomes platform for healthcare providers, industry partners, and researchers. Integrates with major EHRs to automate patient-reported data collection from diagnosis to recovery. Delivers biostatistical analytics for benchmarking, predictive modeling, and visualizations, patient engagement tools, eCRF/ePRO electronic data capture, and registry participation and compliance workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PatientIQ company profile →
123Compliance
HQ: United States
Website
- Description: Provider of compliance-focused solutions for the life science industry, with more than 20 years of experience. As a Salesforce partner, has built and implemented global complaint handling, quality management, regulatory reporting, and document management systems for small and large pharmaceutical and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 123Compliance company profile →
Arlington Medical Resources
HQ: United States
Website
- Description: Provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arlington Medical Resources company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Integrated Proteomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Integrated Proteomics
2.2 - Growth funds investing in similar companies to Integrated Proteomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Integrated Proteomics
4.2 - Public trading comparable groups for Integrated Proteomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →